Predictive Value of Systemic Inflammation Score for Contrast-Associated Acute Kidney Injury and Adverse Outcomes Among Patients Undergoing Elective Percutaneous Coronary Intervention
Ji-Lang Zeng,Yi-Fei Xiang,Li-Wei Zhang,Li-Chuan Chen,Jun-Han Chen,Wen-Jia Liang,Zhebin You,Chang-Xi Wang,Zhi-Jie Lin,Kai-Yang Lin,Yansong Guo
DOI: https://doi.org/10.2147/jir.s419831
IF: 4.5
2023-07-09
Journal of Inflammation Research
Abstract:Ji-Lang Zeng, 1– 3, &ast Yi-Fei Xiang, 1– 3, &ast Li-Wei Zhang, 1– 3, &ast Li-Chuan Chen, 1– 3 Jun-Han Chen, 1– 3 Wen-Jia Liang, 1– 3 Zhebin You, 2– 4 Chang-Xi Wang, 1– 3 Zhi-Jie Lin, 1– 3 Kai-Yang Lin, 1– 3 Yansong Guo 1– 3 1 Department of Cardiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, People's Republic of China; 2 Fujian Provincial Key Laboratory of Cardiovascular Disease, Fujian Provincial Center for Geriatrics, Fujian Provincial Clinical Research Center for Severe Acute Cardiovascular Diseases, Fuzhou, People's Republic of China; 3 Fujian Heart Failure Center Alliance, Fuzhou, People's Republic of China; 4 Fujian Key Laboratory of Geriatrics, Department of Geriatric Medicine, Fujian Provincial Hospital, Fujian Provincial Center for Geriatrics, Fujian Medical University, Fuzhou, Fujian, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yansong Guo; Kai-Yang Lin, Fujian Provincial Hospital, Dongjie Street 134, Fuzhou, Fujian, 350001, People's Republic of China, Tel +86-13559355708, Fax +86-591-87557768, Email ; Purpose: Prior research has demonstrated a key role of systemic inflammatory state in the pathogenesis and progression of contrast-associated acute kidney injury (CA-AKI). Recently, the systemic inflammation score (SIS) has been introduced to evaluate the inflammatory status, utilizing the lymphocyte-to-monocyte ratio (LMR) and albumin. The primary objective of this study was to determine whether the SIS can predict CA-AKI and long-term prognosis in patients undergoing elective percutaneous coronary intervention (PCI). Patients and Methods: A total of 5726 patients who underwent elective PCI were included from January 2012 to December 2018. The primary outcome was CA-AKI, defined as an increase in serum creatinine (SCr) ≥ 0.3 mg/dl or ≥ 50% than baseline SCr within 48 h after the PCI procedure. The secondary outcome was long-term mortality. All patients were classified into low- and high-SIS groups. Results: During hospitalization, 349 (6.1%) patients developed CA-AKI. Multivariate logistic regression analysis showed that patients in the high SIS group had a 1.47-fold higher risk of developing CA-AKI than those in the low SIS group [odds ratio (OR): 1.50, 95% confidence interval (CI): 1.12– 2.01, P =0.006]. Furthermore, the SIS showed the greatest prediction performance for CA-AKI compared with other inflammatory hematological ratios. In the multivariate Cox regression analysis, the high SIS group was found to be closely associated with long-term mortality [hazard ratio (HR): 1.58, 95% CI: 1.26– 1.97, P < 0.001, vs low SIS group]. The Kaplan-Meier curve analysis also demonstrated a difference in long-term mortality between the two groups (Log rank test, P < 0.001). Conclusion: The SIS was closely associated with CA-AKI and long-term mortality in patients after elective PCI. Thus, more attention should be paid to exploring the potential benefits of anti-inflammatory strategies in preventing CA-AKI and improving the prognosis of patients undergoing PCI. Keywords: contrast-associated acute kidney injury, mortality, percutaneous coronary intervention, systemic inflammation score Contrast-associated acute kidney injury (CA-AKI) is a prevalent complication in patients who undergo percutaneous coronary intervention (PCI). The occurrence and development of CA-AKI not only leads to prolonged hospitalization and increased healthcare costs, but is also significantly associated with numerous adverse cardiovascular and renal outcomes, such as heart failure, renal replacement therapy, and major adverse cardiovascular events (MACE). 1–4 Given the limited availability of effective treatments for CA-AKI, identifying modifiable high-risk factors is crucial for implementing preventative strategies and improving prognosis. Prior research has demonstrated a key role of systemic inflammatory state in the pathogenesis and progression of CA-AKI. 5 Several hematological parameters, such as the lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII), have been demonstrated to be closely associated with CA-AKI and other inflammation-related diseases. 6–8 Recently, the systemic inflammation score (SIS), which was constructed based on LMR and albumin, has been developed and shown to be a novel prognostic indicator in several types of cancer. 9 However, the relationship between SIS and CA-AKI remains un -Abstract Truncated-
immunology